Conscious Health webinar highlights

In partnership with Wolff Olins, we recently conducted a study to rank the most Conscious Brands according to consumers. The Conscious Brand index uniquely evaluates brands against multiple ‘conscious’ dimensions, such as taking actions to make the world a better place, driving reform and social change, embracing diversity and inclusivity and inspiring a sense of community.

Three key healthcare and wellness brands ranked in the top 10 globally – Headspace, Pfizer and AstraZeneca. For many, COVID has transformed perceptions of pharma from villain to superhero. The bold and swift actions taken to bring coronavirus vaccines to the public has bolstered faith in an industry historically maligned with mistrust.

The question is, how can healthcare brands sustain this COVID goodwill? And how should this impact their corporate and product brand and marketing going forward? Is it time for pharma to be brave with purposeful, conscious messages and actions beyond COVID?

We invited key individuals in the world of health to discuss the fact that health brands are featuring more prominently for consumers recently and how that should impact the actions of pharmaceutical companies moving forward.

Panelists

Afua Basoah, DPhil

Afua Basoah, DPhil
VP, Head of London
Rabin Martin

Michele Markus

Michele Markus
Head of Global Health Accounts,
Omnicom

David Berman

David Berman
Strategic Advisor,
Bill & Melinda Gates Foundation

Hall & Partners Lottie

Lottie Pollak,
Head of Global Market Research,
GSK

Hall & Partners Mark Earls

Mark Earls,
Behavioural expert and best-selling author

Stacy Vaughn

Stacy Vaughn
Head of US Health,
Hall & Partners

Get in touch today for access to all the Conscious Brands data via the Conscious Data Hub and our latest thinking on the how people’s values have shifted, including case studies and insight news on the latest conscious brand activity.

Stacy Vaughn
Stacy Vaughn
US Head of Health, Hall & Partners Health

Check out more Client Resource articles

What will be the next unpredictable, life-altering event in the healthcare sector?

Why a cultural perspective on health and disease can help us better understand our past, present and future

Hall & Partners appoints talented trio to global leadership team to accelerate growth and implement its new corporate strategy

Why foresight and trends research provides pharma with much-needed agility

3 reasons most segmentations fail

3 strategies for protecting your brand while raising prices

Protecting Your Brand in an Era of High Inflation

Hall & Partners appoints Daiana Dal Col as new CFO

Is the time frame of brand planning holding pharma back from focusing on the future?

Why can’t pharma accurately predict the future?

Previous
Next

Signup for our Newsletter

A monthly newsletter bursting with thinking on how to grow your brand: from in-depth analysis to practical advice. Sign-up for the latest industry perspectives, insight reports, free-to-attend webinars, and exclusive events.

You can view our privacy policy here. By submitting this form you are opting in to receive occasional brand, marketing and communications insights from Hall & Partners